PepGen is a clinical-stage biotechnology company advancing a new generation of oligonucleotide therapies capable of transforming clinical outcomes for individuals with neuromuscular and neurological diseases
PepGen is a clinical-stage biotechnology company advancing a new generation of oligonucleotide therapies capable of transforming clinical outcomes for individuals with neuromuscular and neurological diseases.